CELF4 variant and anthracycline-related cardiomyopathy: A children's oncology group genome-wide association study

Journal of Clinical Oncology

Volumn 34, Issue 8, 2016, Pages 863-870

  Wang, Xuexia ^a   Sun, Can Lan ^b   Quiñones Lombraña, Adolfo ^d   Singh, Purnima ^f   Landier, Wendy ^f   Hageman, Lindsey ^f   Mather, Molly ^b   Rotter, Jerome I ^c   Taylor, Kent D ^c   Chen, Yii Der Ida ^c   Armenian, Saro H ^b   Winick, Naomi ^g   Ginsberg, Jill P ⁱ   Neglia, Joseph P ^j   Oeffinger, Kevin C ^e   Castellino, Sharon M ^k   Dreyer, Zoann E ^h   Hudson, Melissa M ^l   Robison, Leslie L ^l   Blanco, Javier G ^d   Bhatia, Smita ^f   more..

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g UNIVERSITY OF TEXAS AT DALLAS   (United States)

^h TEXAS CHILDREN S CANCER CENTER   (United States)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^j UNIVERSITY OF MINNESOTA   (United States)

^k EMORY UNIVERSITY   (United States)

^l ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CELF PROTEIN; CUGBP ELAV LIKE FAMILY MEMBER 4 PROTEIN; GENOMIC DNA; UNCLASSIFIED DRUG; CELF4 PROTEIN, HUMAN; ISOPROTEIN; TNNT2 PROTEIN, HUMAN; TROPONIN T;

ADULT; AGE; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVOR; CARDIOMYOPATHY; CASE CONTROL STUDY; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; BIOSYNTHESIS; CHEMICALLY INDUCED; DOSE RESPONSE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; INFANT; METABOLISM; NEWBORN; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; ANTHRACYCLINES; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CELF PROTEINS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFANT; INFANT, NEWBORN; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; TROPONIN T; YOUNG ADULT;

EID: 84962536066     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.63.4550     Document Type: Article

References (36)

1. Blanco JG, Sun C-L, Landier W, et al: Anthracycline-related cardiomyopathy after childhood cancer: Role of polymorphisms in carbonyl reductase genes-A report from the Children's Oncology Group. J Clin Oncol 30:1415-1421, 2012
2. Grenier MA, Lipshultz SE: Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol 25:72-85, 1998(suppl 10)
3. Bryant J, Picot J, Levitt G, et al: Cardioprotection against the toxic effects of anthracyclines given to children with cancer: A systematic review. Health Technol Assess 11:iii, ix-x, 1-84, 2007
4. Armenian SH, Ding Y, Mills G, et al: Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation. Br J Haematol 163:205-213, 2013
5. Visscher H, Ross CJD, Rassekh SR, et al; Canadian Pharmacogenomics Network for Drug Safety Consortium: Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol 30:1422-1428, 2012
6. Wojnowski L, Kulle B, Schirmer M, et al: NAD (P) H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicininduced cardiotoxicity. Circulation 112:3754-3762, 2005
7. Wang X, Liu W, Sun C-L, et al: Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group. J Clin Oncol 32:647-653, 2014
8. Lipshultz SE, Lipsitz SR, Kutok JL, et al: Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia. Cancer 119:3555-3562, 2013
9. Hunt SA, Abraham WT, Chin MH, et al:2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines-Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119:e391-e479, 2009
10. Shankar SM, Marina N, Hudson MM, et al; Cardiovascular Disease Task Force of the Children's Oncology Group: Monitoring for cardiovascular disease in survivors of childhood cancer-Report from the Cardiovascular Disease Task Force of the Children's Oncology Group. Pediatrics 121:e387-e396, 2008
11. Purcell S, Neale B, Todd-Brown K, et al: PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575, 2007
12. Cappola TP, Li M, He J, et al: Common variants in HSPB7 and FRMD4B associated with advanced heart failure. Circ Cardiovasc Genet 3:147-154, 2010
13. Lipshultz SE, Alvarez JA, Scully RE: Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart 94:525-533, 2008
14. Kooperberg C, Leblanc M: Increasing the power of identifying gene x gene interactions in genome-wide association studies. Genet Epidemiol 32:255-263, 2008
15. Hsu L, Jiao S, Dai JY, et al: Powerful cocktail methods for detecting genome-wide gene-environment interaction. Genet Epidemiol 36:183-194, 2012
16. Gauderman WJ, Zhang P, Morrison JL, et al: Finding novel genes by testing G × E interactions in a genome-wide association study. Genet Epidemiol 37:603-613, 2013
17. Murcray CE, Lewinger JP, Gauderman WJ: Gene-environment interaction in genome-wide association studies. Am J Epidemiol 169:219-226, 2009
18. Dai JY, Kooperberg C, Leblanc M, et al: Twostage testing procedures with independent filtering for genome-wide gene-environment interaction. Biometrika 99:929-944, 2012
19. Mulrooney DA, Yeazel MW, Kawashima T, et al: Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: Retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 339:b4606, 2009
20. 1, 000 Genomes Project Consortium: A map of human genome variation from population scale sequencing. Nature 467:1061-1073, 2010
21. Ladd AN, Charlet N, Cooper TA: The CELF family of RNA-binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol Cell Biol 21:1285-1296, 2001
22. Ladd AN, Stenberg MG, Swanson MS, et al: Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development. Dev Dyn 233:783-793, 2005
23. Keating BJ, Tischfield S, Murray SS, et al: Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for largescale genomic association studies. PLoS One 3:e3583, 2008
24. Brunak S, Engelbrecht J, Knudsen S: Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol 220:49-65, 1991
25. Horwich TB, Patel J, MacLellan WR, et al: Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 108:833-838, 2003
26. Kismet E, Varan A, Ayabakan C, et al: Serum troponin T levels and echocardiographic evaluation in children treated with doxorubicin. Pediatr Blood Cancer 42:220-224, 2004
27. Gordon AM, Homsher E, Regnier M: Regulation of contraction in striated muscle. Physiol Rev 80:853-924, 2000
28. Kilickap S, Barista I, Akgul E, et al: cTnT can be a useful marker for early detection of anthracycline cardiotoxicity. Ann Oncol 16:798-804, 2005
29. Cooper TA, Ordahl CP: A single cardiac troponin T gene generates embryonic and adult isoforms via developmentally regulated alternate splicing. J Biol Chem 260:11140-11148, 1985
30. Biesiadecki BJ, Elder BD, Yu ZB, et al: Cardiac troponin T variants produced by aberrant splicing of multiple exons in animals with high instances of dilated cardiomyopathy. J Biol Chem 277:50275-50285, 2002
31. Gomes AV, Venkatraman G, Davis JP, et al: Cardiac troponin T isoforms affect the Ca (2+) sensitivity of force development in the presence of slow skeletal troponin I: Insights into the role of troponin T isoforms in the fetal heart. J Biol Chem 279:49579-49587, 2004
32. Anderson PA, Greig A, Mark TM, et al: Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. Circ Res 76:681-686, 1995
33. Hsieh FY, Bloch DA, Larsen MD: A simple method of sample size calculation for linear and logistic regression. Stat Med 17:1623-1634, 1998
34. Murcray CE, Lewinger JP, Conti DV, et al: Sample size requirements to detect gene-environment interactions in genome-wide association studies. Genet Epidemiol 35:201-210, 2011
35. Lin X, Lee S, Christiani DC, et al: Test for interactions between a genetic marker set and environment in generalized linear models. Biostatistics 14:667-681, 2013
36. Pruim RJ, Welch RP, Sanna S, et al: LocusZoom: Regional visualization of genomewide association scan results. Bioinformatics 26:2336-2337, 2010